Table 3.
Probiotics and prebiotics in mood disorders.
| Participants | Treatment | Length of Trial | Measurements | Outcomes | References |
|---|---|---|---|---|---|
| 40 healthy participants without current mood disorders. | Probiotic food-supplement containing B. bifidum W23, B. lactis W52, L. acidophilus W37, L. brevis W63, L. casei W56, L. salivarius W24, and Lactococcus lactis (W19 and W58) (2.5×109CFU/g); placebo. | 4 weeks. | Cognitive reactivity to sad mood using the LEIDS-R. | ↓ overall cognitive reactivity to sad mood by minimizing aggressive thoughts. | [42] |
| 25 subjects with UFC levels less than 50ng/ml. | L. helveticus R0052 and B. longum R0175 (PF). | 30 days. | HADS, and perceived stress. | ↑ HADS score, ↓ anger, depression and anxiety in the UFC patients | [44] |
| 45 healthy patients. | 5.5g of FOS, or B- GOS, or placebo (maldextrin). | 3 weeks. | Salivary cortisol awakening response before and after treatments; processing of emotionally salient information. | Salivary cortisol awakening response ↓ after treatment with B-GOS when compared to placebo. | [45] |
| 25 healthy women. | FMPP containing species B. animalis subsp Lactis, Streptococcus thermophiles, L. bulgaricus, and Lactococcus lactis subsp Lactis (1.2×109 cfu/cup) or a non- fermented milk product twice daily. | 4 weeks. | Brain response to an emotional faces attention task and resting brain activity. | ↓ task-related response of a distributed functional network containing affective, viscerosensory, and somatosensory cortices. FMPP treated women also showed changes in midbrain connectivity. | [46] |
| 172 students undergoing a day medical school exam. | Stressed medical students received LcS-fermented milk or placebo daily. | 8 weeks prior to exam. | Subjective anxiety scores, salivary cortisol levels, and the presence of physical symptoms during the intervention. | ↓ salivary cortisol levels; ↓ rate of physical symptoms. | [47] |
| 40 MDD patients. | Probiotic cocktail (L. acidophilus (2 × 109 CFU/g), L. casei (2 × 109 CFU/g), and B. bifidum (2 × 109CFU/g)); placebo. | 8 weeks. | Dietary intake, depression symptoms, insulin resistance, and glutathione concentrations. | ↓ BDI total scores, ↓ insulin levels and insulin resistance, and ↑ plasma total glutathione levels. | [48] |
| 39 CFS patients. | 24 × 1010 cfu/g of L. casei strain Shirota (LcS); placebo daily. | 2 months. | Flora in stool samples, BDI and BAI scores. | LcS ↑ in both L. and B. and ↓ anxiety symptoms. | [50] |
| 710 young adults (445 females). | Questionnaire on food consumption. | 30 days. | Patients completed self- report measures of fermented food consumption, neuroticism, and social anxiety. | Fermented food consumption correlates with reduced social anxiety and neuroticism. | [51] |
| 66 healthy individuals with <13 HADS-A, and <21 HADS-D scores. | Probiotic mixture containing L. helveticus R0052 and B. longum R0175 (PF). | 30 days | HSCL-90, HADS, PSS, CCL and 24 h UFC level. | Treatment with PF alleviated psychological distress, depression, anger, somatization, and anxiety. | [43] |
Abbreviations: LEID-S, Leiden index of depression sensitivity scale; UFC, Urinary Free Cortisol; HADS, Hospital Anxiety and Depression Scale; FOS, Fructooligosaccharide; B_GOS, Bimuno®-Galactooligosaccharides; FMPP, Fermented Milk Product with Probiotic; MDD, Major Depressive Disorder; BDI, Beck Depression Inventory; CFS, Chronic Fatigue Syndrome; BAI, Beck Anxiety inventory; HSCL-90, Hopkins Symptom Checklist; PSS, Perceived Stress Scale; CCL, Coping Checklist; HADS-A, HADS-anxiety subscale; HADS-D, HADS-depression subscale.